Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 94

Sort by

Sort Order Select

Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.

https://doi.org/10.1182/hematology.2019000006

Published: 2019

Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.

https://doi.org/10.1182/hematology.2019000059

Published: 2019

Journal Articles

In MDS, is higher risk higher reward?

Guillermo F. Sanz

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 381–390.

https://doi.org/10.1182/hematology.2019000042

Published: 2019

Journal Articles

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Jibran Durrani, Jaroslaw P. Maciejewski

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 97–104.

https://doi.org/10.1182/hematology.2019000019

Published: 2019

Journal Articles

Lowering the boom on lower-risk myelodysplastic syndromes

Mikkael A. Sekeres, Bhumika J. Patel

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 367–372.

https://doi.org/10.1182/hematology.2019000040

Published: 2019

Journal Articles

Genetic predisposition to MDS: diagnosis and management

Elissa Furutani, Akiko Shimamura

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 110–119.

https://doi.org/10.1182/hematology.2019000021

Published: 2019

Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.

https://doi.org/10.1182/hematology.2019000041

Published: 2019

Journal Articles

Monitoring and treatment of MDS in genetically susceptible persons

Stella M. Davies

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 105–109.

https://doi.org/10.1182/hematology.2019000020

Published: 2019

Journal Articles

The MDS genomics-prognosis symbiosis

Aziz Nazha

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 270–276.

https://doi.org/10.1182/asheducation-2018.1.270

Published: 2018

Journal Articles

Treatments targeting MDS genetics: a fool’s errand?

Amy E. DeZern

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 277–285.

https://doi.org/10.1182/asheducation-2018.1.277

Published: 2018

Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.

https://doi.org/10.1182/asheducation-2018.1.457

Published: 2018

Journal Articles

Current treatment algorithm for the management of lower-risk MDS

Aristoteles Giagounidis

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 453–459.

https://doi.org/10.1182/asheducation-2017.1.453

Published: 2017

Journal Articles

Aging, hematopoiesis, and the myelodysplastic syndromes

Stephen S. Chung, Christopher Y. Park

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 73–78.

https://doi.org/10.1182/asheducation-2017.1.73

Published: 2017

Journal Articles

Incorporating novel approaches in the management of MDS beyond conventional hypomethylating agents

Olatoyosi Odenike

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 460–469.

https://doi.org/10.1182/asheducation-2017.1.460

Published: 2017

Journal Articles

Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes

Allison H. West, Jane E. Churpek

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 79–87.

https://doi.org/10.1182/asheducation-2017.1.79

Published: 2017

Journal Articles

Inherited bone marrow failure syndromes: considerations pre- and posttransplant

Blanche P. Alter

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 88–95.

https://doi.org/10.1182/asheducation-2017.1.88

Published: 2017

Journal Articles

Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age

Jaroslaw P. Maciejewski, Suresh K. Balasubramanian

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 66–72.

https://doi.org/10.1182/asheducation-2017.1.66

Published: 2017

Journal Articles

Acquired ribosomopathies in leukemia and solid tumors

Adrianna Vlachos

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 716–719.

https://doi.org/10.1182/asheducation-2017.1.716

Published: 2017

Journal Articles

Uncoding the genetic heterogeneity of myelodysplastic syndrome

R. Coleman Lindsley

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 447–452.

https://doi.org/10.1182/asheducation-2017.1.447

Published: 2017

Journal Articles

Pure red cell aplasia

Robert T. Means, Jr

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 51–56.

https://doi.org/10.1182/asheducation-2016.1.51

Published: 2016

NARROW

Minimal residual disease and stem cell transplantation outcomes

Single-agent and combination biologics in acute myeloid leukemia

In MDS, is higher risk higher reward?

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Lowering the boom on lower-risk myelodysplastic syndromes

Genetic predisposition to MDS: diagnosis and management

Integrating patient-centered factors in the risk assessment of MDS

Monitoring and treatment of MDS in genetically susceptible persons

The MDS genomics-prognosis symbiosis

Treatments targeting MDS genetics: a fool’s errand?

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Current treatment algorithm for the management of lower-risk MDS

Aging, hematopoiesis, and the myelodysplastic syndromes

Incorporating novel approaches in the management of MDS beyond conventional hypomethylating agents

Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes

Inherited bone marrow failure syndromes: considerations pre- and posttransplant

Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age

Acquired ribosomopathies in leukemia and solid tumors

Uncoding the genetic heterogeneity of myelodysplastic syndrome

Pure red cell aplasia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only